-
Signature
-
/s/ Benjamin Waters, Attorney-in-Fact
-
Stock symbol
-
GBIO
-
Transactions as of
-
Jan 29, 2024
-
Transactions value $
-
-$2,804
-
Form type
-
4
-
Date filed
-
1/31/2024, 04:30 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
GBIO |
Common Stock |
Options Exercise |
|
+5.02K |
+1.31% |
|
387K |
Jan 29, 2024 |
Direct |
F1 |
transaction |
GBIO |
Common Stock |
Tax liability |
-$2.8K |
-1.48K |
-0.38% |
$1.90 |
386K |
Jan 29, 2024 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
GBIO |
Restricted Stock Units |
Options Exercise |
$0 |
-5.02K |
-100% |
$0.00* |
0 |
Jan 29, 2024 |
Common Stock |
5.02K |
|
Direct |
F1, F2, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Douglas Kerr is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
Explanation of Responses: